Login

Ngopi & Career : Company ONE XOX SDN BHD | Ng Kok Heng, CEO, XOX BhdXOX:KLS 00:10:00

Share On Facebook Share On Twitter

Ng Kok Heng is the Group Chief Executive Officer at XOX BHD.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Blackstone we deliver for investors by building businesses that power tomorrow’s economy|Stephen A. Schwarzman,Chairman,The Blackstone Group
00:10:00
Graham Curren, Founder & CEO of Sondrel, expresses confidence in the company's IPO prospects despite market conditions.
00:10:00
Dominique Senequier Reflects on Pioneering at Ecole Polytechnique and Fostering Entrepreneurship | Dominique Senequier, President, Ardian.
00:10:00
TechCentral Impact Series: Evolution of Cybersecurity with CYBER1 Solutions and Palo Alto Networks | Robert Brown, CEO, Cyber Security 1 ABCYB1:STO
00:10:00
The firm seeks to invest in technology companies based in Europe|Gilbert Kamieniecky,Head,Investcorp Technology Partners
00:10:00
The Relationship Between CDS, Bonds, and Equity Pricing
00:00:00
Inorganic Nitrate Benefits and Tolerability of Exercise Training - Dr. Barry Borlaug, a Cardiologist and Heart Failure Specialist at Mayo Clinic
00:10:00
Insights and updates from the leader of PetVivo Holdings.|Mr. Lai has been a director and senior executive officer of PetVivo Holdings.
00:10:00
Exploring Technology's Role in Healthcare: Insights from Horiba Ltd Chairman | Atsushi Horiba - CEO of Horiba
00:10:00
Overview of Crawford Nickel Project's Market Potential and Sustainability Initiatives
00:10:00
When you have more diverse founders, you see better returns|Katie Jacobs Stanton,Founder and General Partner,Moxxie Ventures
00:10:00
CEO Andrew Hider Reflects: ATS Corporation's Transformative Year Post-IPO | Andrew Hider - CEO of ATS Corp

© 2017 - Neuhu+